|
Press Releases
Dr. Susan Hardin, President and CEO of VisiGen
Biotechnologies Inc. short-listed for 2006 World
Technology Award
New York – October
6, 2006 - The World Technology Network (WTN)
announced today that
Dr. Susan Hardin,
from VisiGen
Biotechnologies Inc., has been short-listed
as a nominee for a 2006 World Technology Award,
presented by the World Technology Network, in
association with the New York Stock Exchange (NYSE), Dow
Chemical, TIME magazine and CNN, among others.
Susan Hardin
is eligible to be selected as the Winner of the
2006 World Technology Award for Health and Medicine.
Winners will be announced on November 3rd, 2006, in San
Francisco, at the World Technology Awards gala ceremony
at San Francisco City Hall at the conclusion of the
two-day World Technology Summit. The World Technology
Awards honor individuals and corporations from twenty
(20) technology-related sectors viewed by their peers as
being the most innovative and doing the work of the
greatest likely long-term significance. Award
categories range from biotechnology, space and energy
through to ethics, design and entertainment.
Susan Hardin commented: “I am honored to be
identified by my peers as a finalist for the World
Technology Award for Health and Medicine.”
Nominees for the 2006 World Technology Awards were
identified based on an intensive, global process over a
period of many months in which current individual WTN
members (primarily elected WTN Fellows from previous
Awards cycles), who now number over 800, spread out over
60 countries) made their nominations based on who they
think is doing the innovative work in their field of the
greatest likely long-term significance. After the WTN
gathers further information from and about nominees, WTN
individual members then vote on their preferences within
their category. The top five selections (sometimes a few
more, in the case of ties) are then inducted into our
WTN membership base as Fellows, with one of them
announced as the Winner of their Award category at the
Awards ceremony.
A small selection of those WTN members in the 20
different award categories who nominated/judged/voted in
the past two years can be found at this website: http://www.wtn.net/members/individual.html
James P. Clark, founder and Chairman of the World
Technology Network, added:
“The World Technology Awards program is not only a
very inspiring way to identify and honor the most
innovative people and organizations in the technology
world, but it also is a truly disciplined way for the
WTN membership to identify those who will formally join
them, as WTN Fellows, as part of our global community.
By working to make useful connections among our members,
we look forward to assisting Dr. Hardin continue to help
create our collective future and change our world."
This year’s World Technology Awards ceremony will cap
the 2006 World Technology Summit taking place in San
Francisco on the 2nd and 3rd of November, at the
historic Fairmont Hotel. The Summit will also include a
Chief Technology Officer (CTO) Showcase, enabling a
small selection of companies to discuss and “demo” their
work in detail with Summit delegates. For more
information on the World Technology Network, World
Technology Awards and World Technology Summit, please
visit this website:
www.wtn.net
About World Technology Network
The World Technology Network is a New York-headquartered
organization that was created to "encourage serendipity"
- happy accidents - amongst those individuals and
companies deemed by their peers to be the most
innovative in the science and technology world. The
WTN's areas of interest range from IT and communications
to biotech, energy, materials, space, as well as related
fields such as finance, marketing, policy, law, design,
and ethics. Each year, WTN members are brought together
through an ongoing global series of regional
roundtables, global Summits, and other events. The WTN
also convened the World Energy Technologies Summit at
UNESCO headquarters in Paris. The WTN also publishes
"The WTN Update”, a monthly collection of news items
covering the innovative work of the WTN members. The
central events in the WTN calendar include the annual
World Technology Summit and World Technology Awards -
the culmination of a global judging program through
which new members are nominated and selected and by
which the network grows and is refreshed.
About Dr. Susan
Hardin
Dr. Susan Hardin received an undergraduate degree in
Biology at Penn State University in 1982, and a Ph.D. in
Molecular, Cellular, and Developmental Biology from
Indiana University in 1987. She performed postdoctoral
work at Brandeis University in Waltham Massachusetts.
Dr. Hardin became the Director of the Gene Technologies
Laboratory at Texas A&M University in 1991, joined the
faculty at the University of Houston as an Assistant
Professor of Biology and Biochemistry in 1995, and was
promoted to Associate Professor in 2002. In August 2005,
she resigned her tenured professorship, but retains
Adjunct Professor status.
Dr. Hardin is an active member of the Association of
Biomolecular Research Facilities and was elected to the
ABRF Executive Board. She is a 2004 American Women in
Computing, Houston, Top Women in Technology Honoree, and
was recently inducted to the American Institute of
Medical and Biological Engineering 2006 College of
Fellows. In 2006 she will also receive a Penn State Eberly College of Science Outstanding Science Alumni
Award. "The Outstanding Science alumni Awards are
presented annually to recognize and reward outstanding
Penn State alumni for their success as leaders in
science and for the impact they have had and will
continue to have on society and their professions."
Dr. Hardin's research interests are in the areas of
molecular genetics and biotechnology, especially with
respect to the mechanisms of enzymatic DNA synthesis and
DNA replication. She has published papers on novel
methods for sequencing DNA, has issued patents, and
several patents pending.
About VisiGen
VisiGen, a privately-held company based in Houston, TX, is developing a radically new method of sequencing DNA that is projected to completely sequence a human genome in a day for the long-coveted target mark of $1000. Its technology is distinguished from other next generation sequencing technologies in that it exploits the natural process of DNA replication in a way that enhances accuracy without drastically impacting efficiency. VisiGen’s approach involves engineering both polymerase and nucleotide triphosphates to act together as direct molecular sensors of DNA base identity in real-time. The massively parallel nature of this technology enables sequence acquisition at rates approaching 1 million bases per second per machine.
Contact Information
Susan Hardin
President and CEO
VisiGen Biotechnologies, Inc.
shardin@visigenbio.com
James P. Clark
Founder and Chairman
World Technology Network
jpclark@wtn.net
415 839 6358
|